Sponsor or institution
Clinical trials and research at GRIN Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by GRIN Therapeutics, Inc. that are recruiting, at sites in 10 countries (most in United States (2), Belgium (1), France (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 10Countries
All recruiting trials (2)
-
Radiprodil for adults with liver impairment
It will test whether a single 15 mg oral dose of radiprodil is processed differently and tolerated safely in adults with mild, moderate, or severe liver impairment compared with healthy adults.
-
Beeline Phase 3: radiprodil for GRIN-related neurodevelopmental disorder
This Phase 3 test will see if radiprodil can reduce seizures and improve developmental and behavioral symptoms in people with GRIN-related neurodevelopmental disorder caused by gain-of-function GRIN gene variants.
Quick answers
How many clinical trials run by GRIN Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (2 trials), Belgium (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.